from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1683/-

LFCtreatmentdescriptionclass of inhibitor

0.057

Amikacinug/mL Amikacintranslation

0.146

Cap5-10ug/mL Capreomycintranslation

-0.324

Rox10-50 ug/mL Roxithromycintranslation

-0.125

SM2-5 ug/mL Streptomycintranslation

0.023

Tet5-10 ug/mL Tetracyclinetranslation

0.417

Rif0.2-5ug/mL Rifampicintranscription

0.340

Rifp0.1-0.5ug/mL Rifapentinetranscription

-3.210

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.668

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.257

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.322

Clofazimine10-13 ug/mL Clofaziminerespiration

0.248

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.507

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.712

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.213

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.598

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.472

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.595

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.067

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.255

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.257

KCN5-20 ug/mL Potassium cyaniderespiration

0.439

NaN30.2-2 mM Sodium aziderespiration

1.603

Nigericin50 uM Nigericinrespiration

0.010

TRC10-150 ug/mL Triclosanrespiration

-0.719

TRZ10-25 ug/mL Thioridazinerespiration

-0.329

Valinomycin0.5-10 uM Valinomycinrespiration

0.136

ZnSO42 mM ZnSO4respiration

-0.501

menadione6-10 ug/mL Menadionerespiration

-0.906

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.068

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.687

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.273

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.378

NRP_1Non-replicating persistence stage 1dosRassociated

0.173

Amp0.2mg/mL AmpicillincellWall

0.313

Cephalexin20-100 ug/mL CephalexincellWall

-0.315

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.249

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.360

EMB10-20 ug/mL EthambutolcellWall

0.139

Eta12-40 ug/mL EthionamidecellWall

0.348

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.032

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.832

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.027

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.570

BZA0.12 mg/mL BenzamidearomaticAmides

-0.145

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.435

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.357

H2O24 mM hydrogen peroxideDNAdamaging

0.093

Levo10 ug/mL LevofloxacinDNAdamaging

0.413

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.721

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.355

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.339

UVUV-irradiationDNAdamaging

-2.010

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.002

Antimycin12.5-50 ug/mL Antimycin A?

-0.116

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.025

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.210

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.546

PA8240.2-2 ug/mL PA-824?

1.942

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.829

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.621

Verapamil50 uM Verapamil?

0.091

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.545

methoxatin10-20 ug/mL Methoxatin?